Meridian Bioscience Stock

Meridian Bioscience Inventory

The Inventory of Meridian Bioscience (VIVO) as of Sep 11, 2026 is 67.81 M USD. In the previous year, Inventory was 76.84 M USD — a change of -11.75% (lower).

Inventory

67.81 MUSD

YoY

-11.75%

Last updated:

Inventory of Meridian Bioscience is 2026 67.81 M USD. Inventory of Meridian Bioscience was 2025 76.84 M USD. It decreases by -11.75% lower compared to the previous year.

The Meridian Bioscience Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2015
35.80 M USD
Jan 1, 2016
45.10 M USD
Jan 1, 2017
41.50 M USD
Jan 1, 2018
42.00 M USD
Jan 1, 2019
39.60 M USD
Jan 1, 2020
61.30 M USD
Jan 1, 2021
76.84 M USD
Jan 1, 2022
67.81 M USD
The Meridian Bioscience Inventory history
YEARInventoryYoY
67.81 MUSD-11.75%
76.84 MUSD+25.35%
61.30 MUSD+54.80%
39.60 MUSD-5.71%
42.00 MUSD+1.20%
41.50 MUSD-7.98%
45.10 MUSD+25.98%
35.80 MUSD+0.85%
35.50 MUSD
Access this data via the Eulerpool API

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

Inventory of Meridian Bioscience is 67.81 M USD in 2026.

Inventory of Meridian Bioscience changed from 76.84 M USD to 67.81 M USD, representing a -11.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Meridian Bioscience historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Meridian Bioscience

All Key Metrics — Meridian Bioscience